HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ten years' experience of treating lentigo maligna with topical azelaic acid.

Abstract
Topically applied azelaic acid led to complete clinical and histological resolution of lentigo maligna in more than 50 patients. The therapeutic results are highly durable, in fact 27 out of the 50 are still disease-free, 5-10 years after treatment. There was a recurrence in 11 cases, but all resolved on renewing treatment. The effect of azelaic acid is illustrated in a patient with lentigo maligna monitored clinically, histologically and ultrastructurally over the past 5 years.
AuthorsM Nazzaro-Porro, S Passi, G Zina, A S Breathnach
JournalActa dermato-venereologica. Supplementum (Acta Derm Venereol Suppl (Stockh)) Vol. 143 Pg. 49-57 ( 1989) ISSN: 0365-8341 [Print] Norway
PMID2773614 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Dicarboxylic Acids
  • azelaic acid
Topics
  • Administration, Topical
  • Aged
  • Dicarboxylic Acids (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Lentigo (drug therapy, pathology)
  • Melanocytes (ultrastructure)
  • Microscopy, Electron
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: